Dr. David D. Chism
Claim this profileThompson Cancer Survival Center
Studies Cancer
Studies Prostate Cancer
14 reported clinical trials
42 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
PD-L1 positive
2Prostate Cancer
Stage IV
Affiliated Hospitals
Thompson Cancer Survival Center
Thompson Oncology Group-Oak Ridge
Clinical Trials David D. Chism is currently running
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
Nivolumab + Chemotherapy
for Anal Cancer
This trial is testing whether adding nivolumab to standard chemotherapy is more effective for patients with metastatic anal cancer. Nivolumab helps the immune system fight cancer, while chemotherapy kills or stops cancer cells from growing. Nivolumab has shown significant effectiveness in treating metastatic squamous cell carcinoma of the anal canal.
Recruiting2 awards Phase 321 criteria
More about David D. Chism
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments David D. Chism has experience with
- Nivolumab
- Atezolizumab
- Carboplatin
- Oxaliplatin
- Paclitaxel
- Ipilimumab
Breakdown of trials David D. Chism has run
Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David D. Chism specialize in?
David D. Chism focuses on Cancer and Prostate Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is David D. Chism currently recruiting for clinical trials?
Yes, David D. Chism is currently recruiting for 4 clinical trials in Knoxville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that David D. Chism has studied deeply?
Yes, David D. Chism has studied treatments such as Nivolumab, Atezolizumab, Carboplatin.
What is the best way to schedule an appointment with David D. Chism?
Apply for one of the trials that David D. Chism is conducting.
What is the office address of David D. Chism?
The office of David D. Chism is located at: Thompson Cancer Survival Center, Knoxville, Tennessee 37916 United States. This is the address for their practice at the Thompson Cancer Survival Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.